Enlivex Therapeutics Ltd
NASDAQ:ENLV

Watchlist Manager
Enlivex Therapeutics Ltd Logo
Enlivex Therapeutics Ltd
NASDAQ:ENLV
Watchlist
Price: 1.23 USD -0.81%
Market Cap: 27m USD
Have any thoughts about
Enlivex Therapeutics Ltd?
Write Note

Enlivex Therapeutics Ltd
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Enlivex Therapeutics Ltd
Other Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Enlivex Therapeutics Ltd
NASDAQ:ENLV
Other Liabilities
$499k
CAGR 3-Years
7%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Other Liabilities
$2.5m
CAGR 3-Years
-5%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Other Liabilities
$52.4m
CAGR 3-Years
119%
CAGR 5-Years
113%
CAGR 10-Years
20%
Urogen Pharma Ltd
NASDAQ:URGN
Other Liabilities
$121.9m
CAGR 3-Years
14%
CAGR 5-Years
135%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Other Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pluri Inc
NASDAQ:PLUR
Other Liabilities
$5.6m
CAGR 3-Years
75%
CAGR 5-Years
20%
CAGR 10-Years
3%
No Stocks Found

Enlivex Therapeutics Ltd
Glance View

Market Cap
25.7m USD
Industry
Biotechnology

Enlivex Therapeutics Ltd. develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions. AllocetraTM is a therapy designed to reprogram macrophages into their homeostatic state. Diseases such as solid cancers, sepsis, COVID-19 and many others reprogram macrophages out of their homeostatic state. These non-homeostatic macrophages contribute significantly to the severity of the respective diseases. By restoring macrophage homeostasis, AllocetraTM has the potential to provide immunotherapeutic mechanism of action for life-threatening clinical indications that are defined as unmet medical needs, as a stand-alone therapy or in combination with therapeutic agents.

ENLV Intrinsic Value
1.18 USD
Overvaluation 4%
Intrinsic Value
Price

See Also

What is Enlivex Therapeutics Ltd's Other Liabilities?
Other Liabilities
499k USD

Based on the financial report for Jun 30, 2024, Enlivex Therapeutics Ltd's Other Liabilities amounts to 499k USD.

What is Enlivex Therapeutics Ltd's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
13%

Over the last year, the Other Liabilities growth was -87%. The average annual Other Liabilities growth rates for Enlivex Therapeutics Ltd have been 7% over the past three years , 13% over the past five years .

Back to Top